Microemulsion
Microemulsions are thermodynamically stable, optically
transparent, isotropic dispersions of aqueous and hydrocarbon liquids
stabilized by an interfacial film of surfactant molecules.
Microemulsions are monodispersed spherical droplets
(droplet size below 0.15 µm) of water in
oil, oil in water or may even be bicontinuous, depending on the nature of the
continuous phase. The HLB value of the surfactant is an essential criteria to
be considered in the formulation of emulsions.
In this type of system, the two liquids tend to separate
out in two layers. And to avoid this, a third substance called as an emulsifier
is added, act by:
a)
They tend to adsorb at
interface, where they can fulfill their dual affinity with hydrophilic groups
located in aqueous phase and hydrophobic groups in oil or air.
b)
They reduce the
mismatch with solvent through a specific kind of aggregation process known as
micellization.
History
The Microemulsion concept was introduced as early as 1940s
by Hoar and Schulman who generated a clear single-phase mixture by
titrating a milky emulsion with hexanol. Schulman and co-workers (1959)
subsequently coined the term microemulsion.
Synonyms: Transparent emulsion, Swollen micelle, Micellar
solution, Solubilized oil
In recent years, micro emulsion drug delivery system, is
a promising delivery systems which
allow sustained or controlled drug
release for percutaneous, peroral,
topical, transdermal, ocular and parenteral administration of medicaments.
Properties
Spontaneous formation, Ease of manufacturing and scale-up, better
alternative drug carrier, Thermodynamic stability, Improved drug solubilization
of hydrophobic drugs and bioavailabilty & Increased absorption.
Advantages
1)
Thermodynamically
stable system
2)
They can solubilize
hydrophilic and lipophilic drugs including drugs that are insoluble relatively
insoluble in any of them.
3)
The small size of
droplets in microemulsions e.g. below <0.15µ, yields very large interfacial
area.
4)
Microemulsion have low
viscosity compared to other emulsion.
5)
It increases the
bioavailability of drug molecule.
6)
They may become
unstable at low or high temperature but when the temperature returns to the
stability range, the microemulsion reforms.
7)
Decreased pain
sensation at injected site.
Disadvantages
1)
A large concentration
of surfactant and co-surfactant necessary for stabilizing the nanodroplets.
2)
The surfactant must be
non-toxic for use in pharmaceutical applications.
3)
Microemulsion
stability is influenced by environmental parameters such as temperature and pH.
These parameters change upon microemulsion delivery to patients.
Type of Microemulsion System
Constituents of Microemulsion
Oil phase :- Isopropyl Myristate , Oleic acid , Olive oil, Mineral oil,
Medium chain triglyceride, Soybean oil ,
Captex 355, Isopropyl palmitate , Sunflower Oil, Safflower Oil .
Surfactants :- Tween 80, Tween 40, Labrafil M1944CS,
Polyoxyethylene-35-ricinoleate, Brij 58,
Span 80, Cremophor EL Labrasol , Cremophor RH,Lecithin .
Cosurfactant/Stabilizer :- Propylene glycol, Cremphor RH 40, Ethylene glycol, Ethanol,
1-butanol, Isopropyl alcohol, PEG 600, Glycerol,
PEG 400, Sodium Oleate .
Formation of
microemulsion
Micro emulsion is formed when the interfacial tension at
the O/W interphase are brought very low
level. The interfacial tension is kept highly flexible.
Role of surfactant
1)
The surfactant used to
stabilize the micro emulsion system are:
–
Non ionic
–
Zwitter ion
–
Cationic
–
Anionic
2)
The use of hydrophilic
surfactant oil produces swollen type of oil-in-water micro emulsion.
3)
The use of lipophilic
surfactant produces water swollen type of water-in oil micro emulsion.
4)
The combination of
ionic and nonionic surfactant , can be very effective at the microemulsion
region.
Role of temperature
The effect of change of temperature at the maximum
solubility is very high as the rate of solubilization increases. If temperature
insensitive three phase system are produced, micro emulsion are stable against
temperature change.
Phase Behaviour
The phase behaviour of simple microemulsion system can be
studied by the aid of ternary phase diagram (at fixed pressure and temperature)
in which each corner of the diagram represents 100% concentration of that
component. For four or more components pseudo ternary phase diagrams are used
to study the phase behaviour.In this diagram a corner represent a binary
mixture of two components such as water/drug, oil/drug or
surfactant/co-surfactant. The number of different phases present for a
particular mixture can be visually assessed. With high oil concentration surfactant forms
reverse micelles capable of solubilizing water molecules in their hydrophilic
interior.
Continued addition of water in this system may result in
the formation of W/O micro emulsion in which water exists as droplets
surrounded and stabilized by interfacial layer of the surfactant /
co-surfactant mixture. At a limiting water content, the isotropic clear region
changes to a turbid, birefringent one. Upon further dilution with water, a
liquid crystalline region may be formed in which the water is sandwiched
between surfactant double layers. Finally, as amount of water increases, this
lamellar structure will break down and water will form a continuous phase
containing droplets of oil stabilized by a surfactant / co-surfactant (O/W
microemulsions)
Spontaneous Emulsification Process
This procedure comprises the following steps:
1)
Dissolving the oil
phase containing phospholipid in the alcoholic solution;
2)
Optionally dissolving
the drug into the oily alcoholic phase and
3)
Mixing the product of
step (2) with an aqueous preparation of surfactant. forming an oil-in-water
emulsion. And
4)
Removing (atleast most
of) co-solvent which is present.
The emulsions exhibited a mean droplet size in the range
200-300 nm. The results indicated that emulsions prepared by this method are
very stable. hey can also be sterilized by heat sterilization or by filtration.
SolEmuls Technology
1)
Drug-loaded emulsions
are produced either by adding the powdered drug to the emulsion by stirring or
alternatively by preparing a finely wet-milled drug suspension which was mixed
with the emulsions by gentle stirring.
2)
The obtained
dispersions containing oil droplets and drug crystals are then subjected to a
high pressure homogenization process.
3)
Production is
performed typically at 45◦C applying 1500 bar
and 1–20 homogenization cycles.
No comments:
Post a Comment